chr1-234609306-G-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_182972.3(IRF2BP2):c.189C>A(p.His63Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000481 in 1,497,258 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_182972.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF2BP2 | ENST00000366609.4 | c.189C>A | p.His63Gln | missense_variant | Exon 1 of 2 | 1 | NM_182972.3 | ENSP00000355568.3 | ||
IRF2BP2 | ENST00000366610.8 | c.189C>A | p.His63Gln | missense_variant | Exon 1 of 2 | 1 | ENSP00000355569.3 | |||
LINC00184 | ENST00000796406.1 | n.12G>T | non_coding_transcript_exon_variant | Exon 1 of 4 | ||||||
ENSG00000228830 | ENST00000436039.1 | n.631-115G>T | intron_variant | Intron 1 of 1 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151370Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.0000561 AC: 6AN: 106954 AF XY: 0.0000830 show subpopulations
GnomAD4 exome AF: 0.0000505 AC: 68AN: 1345888Hom.: 0 Cov.: 34 AF XY: 0.0000587 AC XY: 39AN XY: 664450 show subpopulations
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151370Hom.: 0 Cov.: 30 AF XY: 0.0000406 AC XY: 3AN XY: 73930 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.189C>A (p.H63Q) alteration is located in exon 1 (coding exon 1) of the IRF2BP2 gene. This alteration results from a C to A substitution at nucleotide position 189, causing the histidine (H) at amino acid position 63 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Immunodeficiency, common variable, 14 Uncertain:1
This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF: 0.01% [2/15210]; https://gnomad.broadinstitute.org/variant/1-234609306-G-T?dataset=gnomad_r3). This variant is also present in ClinVar (Variation ID: 1448760). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
not provided Uncertain:1
This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 63 of the IRF2BP2 protein (p.His63Gln). This variant is present in population databases (rs754511640, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with IRF2BP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1448760). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at